Upregulation of PSMA Expression by Enzalutamide in Patients with Advanced mCRPC

SIMPLE SUMMARY: The prostate-specific membrane antigen (PSMA) which shows overexpression on the cell surface of prostate cancer cells, provides a specific target for molecular imaging and radioligand therapy. In this study, we investigated PSMA upregulation by enzalutamide, an established androgen a...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosar, Florian, Neher, Robert, Burgard, Caroline, Linxweiler, Johannes, Schreckenberger, Mathias, Hoffmann, Manuela A., Bartholomä, Mark, Khreish, Fadi, Ezziddin, Samer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997007/
https://www.ncbi.nlm.nih.gov/pubmed/35406467
http://dx.doi.org/10.3390/cancers14071696

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997007/
https://www.ncbi.nlm.nih.gov/pubmed/35406467
http://dx.doi.org/10.3390/cancers14071696

Ejemplares similares